Reduction in blood pressure in patients treated with vildagliptin as monotherapy or in combination with metformin for type 2 diabetes

被引：0
|
作者：
Nathwani, Ameet
Lebeaut, Alexandre
Byiers, Stuart
Gimpelewicz, Claudio
Chang, Ih
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A113 / A113
页数：1
相关论文
共 50 条
  • [31] Vildagliptin significantly decreases blood pressure (BP) in hypertensive patients (pts) with type 2 diabetes (T2DM) compared with metformin
    Bosi, E.
    Byiers, S. R.
    Cohen, S. E.
    DIABETES, 2007, 56 : A139 - A139
  • [32] Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin uptitration in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy: a randomized, open-label, prospective study (VISION)
    Ji, L-N
    Pan, C-Y
    Lu, J-M
    Li, H.
    Zhu, D-L
    Li, Q.
    Li, Q-F
    Peng, Y-D
    Tian, H-M
    Yao, C.
    Zhao, Z-G
    Wang, L.
    Wang, B-H
    DIABETES OBESITY & METABOLISM, 2016, 18 (08): : 775 - 782
  • [33] Improved blood pressure (BP) lowering in hypertensive patients (pts) with type 2 diabetes (T2DM) with vildagliptin combined with metformin compared with metformin alone
    Bosi, E.
    Shao, Q.
    Cohen, S. E.
    DIABETES, 2007, 56 : A549 - A549
  • [34] Comparison of vildagliptin and pioglitazone in patients with type 2 diabetes inadequately controlled with metformin
    Bolli, G.
    Dotta, F.
    Colin, L.
    Minic, B.
    Goodman, M.
    DIABETES OBESITY & METABOLISM, 2009, 11 (06): : 589 - 595
  • [35] CLINICAL & ECONOMIC EFFECTIVENESS OF USING VILDAGLIPTIN IN ADULT PATIENTS WITH TYPE 2 DIABETES UNDERGOING METFORMIN MONOTHERAPY WITH UNSATISFACTORY GLYCEMIC CONTROL
    Almadiyeva, A.
    Akanov, Z.
    Absattarova, K.
    Sultanov, M.
    VALUE IN HEALTH, 2018, 21 : S122 - S122
  • [36] Comparison of metformin, gliclazide MR and rosiglitazone in monotherapy and in combination for type 2 diabetes
    Vilar, Lucio
    Canadas, Viviane
    Arruda, Maria Juliana
    Arahata, Carla
    Agra, Rodrigo
    Pontes, Lisete
    Montenegro, Larissa
    Vilar, Clarice Freitas
    Moura e Silva, Lidiane
    Albuquerque, Jose Luciano
    Gusmao, Amaro
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2010, 54 (03) : 311 - 318
  • [37] Effect of Vildagliptin and Metformin Combination Therapy on Liver Fat Content in Type 2 Diabetes Mellitus
    Chen, Zaoping
    Liu, Jun
    Hang, Xinmei
    DIABETES, 2015, 64 : A508 - A508
  • [38] Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France
    Vexiau, P.
    Mavros, P.
    Krishnarajah, G.
    Lyu, R.
    Yin, D.
    DIABETES OBESITY & METABOLISM, 2008, 10 : 16 - 24
  • [39] Alogliptin plus metformin combination therapy vs alogliptin or metformin monotherapy for type 2 diabetes mellitus
    Pratley, R.
    Wilson, C.
    Fleck, P.
    DIABETOLOGIA, 2012, 55 : S347 - S348
  • [40] Use of metformin and vildagliptin for treatment of type 2 diabetes in the elderly
    Sicras-Mainar, Antoni
    Navarro-Artieda, Ruth
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 811 - 818
12345